Wave Life Sciences Ltd

(NASDAQ:WVE)

Latest On Wave Life Sciences Ltd (WVE):

Date/Time Type Description Signal Details
2023-05-23 19:33 ESTNewsWave Life Sciences crashes on decision to drop neurology asset on trial setbackN/A
2023-05-03 17:10 ESTNewsWave Life Sciences GAAP EPS of -$0.27 misses by $0.23, revenue of $12.93M misses by $25.67MN/A
2023-05-03 17:10 ESTNewsWave Life Sciences Ltd. (WVE) Q1 2023 Earnings Call TranscriptN/A
2023-05-02 16:03 ESTNewsWave Life Sciences Q1 2023 Earnings PreviewN/A
2023-03-22 19:19 ESTNewsWave Life Sciences GAAP EPS of -$0.47 misses by $0.06, revenue of $1.24M misses by $1.16MN/A
2023-03-22 19:18 ESTNewsWave Life Sciences Ltd. 2022 Q4 - Results - Earnings Call PresentationN/A
2023-03-22 19:18 ESTNewsWave Life Sciences Ltd (WVE) Q4 2022 Earnings Call TranscriptN/A
2023-03-21 11:59 ESTNewsWave Life Sciences Q4 2022 Earnings PreviewN/A
2023-03-13 05:38 ESTNewsRAPT Therapeutics, Repare Therapeutics among biotechs to disclose exposure to Silicon Valley BankN/A
2023-01-08 08:22 ESTNewsWave Life Sciences: Huntington's Hypotheses, GSK Collaboration Catalysts To Move The NeedleN/A
2022-12-13 14:27 ESTNewsWave Life stock surges 20% in team up with GSK for genetic diseasesN/A
2022-11-11 01:23 ESTNewsWave Life Sciences Ltd. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-11 01:23 ESTNewsWave Life Sciences Ltd. (WVE) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 07:50 ESTNewsWave Life Sciences GAAP EPS of -$0.42 beats by $0.08, revenue of $0.29M misses by $5.11MN/A
2022-11-09 14:49 ESTNewsWave Life Sciences Q3 2022 Earnings PreviewN/A
2022-09-21 00:13 ESTNewsWave Life's WVE-003 shows promise in interim data of Huntington's disease trialN/A
2022-08-11 17:59 ESTNewsWave Life Sciences GAAP EPS of -$0.62 misses by $0.08, revenue of $0.37MN/A
2022-08-11 17:59 ESTNewsWave Life Sciences Ltd. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-11 17:59 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 01:42 ESTNewsWave Life Sciences Q2 2022 Earnings PreviewN/A
2022-06-22 10:01 ESTNewsRa Capital Management raises passive stake in Wave Life SciencesN/A
2022-06-15 00:46 ESTNewsWave Life Sciences to raise $70M in stock offeringN/A
2022-05-14 05:36 ESTNewsWave Life Sciences Ltd.'s (WVE) CEO Paul Bolno on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-14 05:36 ESTNewsWave Life Sciences slips as H.C. Wainwright lowers targetN/A
2022-05-13 02:49 ESTNewsWave Life Sciences GAAP EPS of -$0.62 misses by $0.06, revenue of $1.75M misses by $2.11MN/A
2022-05-13 02:49 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-13 02:49 ESTNewsWave Life Sciences Ltd. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-12 06:46 ESTNewsWave Life Sciences Q1 2022 Earnings PreviewN/A
2022-04-05 01:08 ESTNewsWave Life gains most in more than a year after early-stage data for ALS drugN/A
2022-03-31 02:14 ESTNewsWave Life Sciences (WVE) Investor Presentation - SlideshowN/A
2022-03-05 07:12 ESTNewsWave Life Sciences Ltd. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-03-03 20:07 ESTNewsWave Life Sciences GAAP EPS of -$0.61 misses by $0.06, revenue of $1.76M misses by $11.98MN/A
2022-03-03 20:06 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-03 02:56 ESTNewsWave Life Sciences Q4 2021 Earnings PreviewN/A
2022-01-25 21:00 ESTNewsWave Life Sciences' FTD, ALS clinical program to get investment from 2 organizationsN/A
2021-11-10 18:38 ESTNewsWave Life Sciences EPS beats by $0.52, beats on revenueN/A
2021-11-10 18:37 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-10 18:37 ESTNewsWave Life Sciences Ltd. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-09 19:57 ESTNewsWave Life Sciences Q3 2021 Earnings PreviewN/A
2021-10-18 23:49 ESTNewsWave Life Sciences, Takeda amend CNS research collaborationN/A
2021-10-18 23:49 ESTNewsTakeda discontinues research with Wave for certain CNS programs; Wave to get $22.5MN/A
2021-09-30 02:27 ESTNewsDosing underway in Wave Life's mid-stage WVE-N531 study in Duchenne muscular dystrophyN/A
2021-09-29 03:19 ESTNewsWave Life Sciences falls after presentation on its RNA editing capability (Updated)N/A
2021-09-09 14:39 ESTNewsWave Life Sciences gets dosing underway in early-stage Huntington’s disease trialN/A
2021-08-17 03:33 ESTNewsWave Life Sciences Ltd. 2021 Q2 - Results - Earnings Call PresentationN/A
2021-08-08 22:24 ESTNewsWave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-05 16:13 ESTNewsWave Life Sciences EPS misses by $0.14, misses on revenueN/A
2021-07-22 09:27 ESTNewsWave Life Sciences posts proof-of-concept data from genetic disorder studyN/A
2021-07-22 08:54 ESTNewsDosing underway in Wave Life Sciences' mid-stage WVE-004 study in neurodegenerative diseasesN/A
2021-03-29 20:19 ESTNewsWave Life Sciences falls on setback for Huntington’s disease trial (updated)N/A

About Wave Life Sciences Ltd (WVE):

Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company is primarily developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. It develops WVE-120101 and WVE-120102, a stereopure therapeutic candidates, which are in Phase 1b/2a clinical trials for the treatment of Huntington's disease (HD); WVE-003, mutant huntingtin SNP3 program for the treatment of HD; WVE-004, C9orf72 program for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia; WVE-N531, our Exon 53 program for the treatment of Duchenne muscular dystrophy; and ATXN3 program in SCA3. The company has collaboration agreements with Pfizer Inc., Takeda Pharmaceutical Company Limited, University of Oxford, and University of Massachusetts. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore.

See Advanced Chart

General

  • Name Wave Life Sciences Ltd
  • Symbol WVE
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 217
  • Fiscal Year EndDecember
  • IPO Date2015-11-11
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.wavelifesciences.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 17.92
  • Price/Book (Most Recent Quarter) 5.85
  • Enterprise Value Revenue 16.38
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.80
  • Next Year EPS Estimate -$2.16
  • Next Quarter EPS Estimate -$0.53
  • Operating Margin -764%
  • Return on Assets -34%
  • Return on Equity -185%
  • Revenue 20.08 million
  • Earnings Per Share -$5.15
  • Revenue Per Share $0.51
  • Gross Profit -110867000
  • Quarterly Earnings Growth 293.3%
View More

Highlights

  • Market Capitalization 486.05 million
  • EBITDA -173971008
  • PE Ratio -9.74
  • Analyst Target Price $16.86
  • Book Value Per Share $1.70
View More

Share Statistics

  • Shares Outstanding 49 million
  • Shares Float 31.16 million
  • % Held by Insiders 1297%
  • % Held by Institutions 76.71%
  • Shares Short 4.92 million
  • Shares Short Prior Month 4.38 million
  • Short Ratio 9.71
  • Short % of Float 13%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 0.37
  • 52 Week High $19.98
  • 52 Week Low $6.76
  • 50 Day Moving Average 10.18
  • 200 Day Moving Average 9.71
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Wave Life Sciences Ltd (WVE) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Wave Life Sciences Ltd (WVE) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-04$9.44 million-$0.59-$0.602.14%
2020-09-302020-11-09$N/A-$0.86-$0.73-17.81%
2020-06-302020-08-10$N/A-$1.15-$1.07-7.48%
2020-03-312020-05-11$4.16 million-$1.38-$1.32-4.41%
2019-12-312020-03-02$2.4 million-$1.65-$1.46-13.35%
2019-09-302019-11-05$2.93 million-$1.48-$1.37-8.37%
2019-06-302019-07-29$7.63 million-$1.22-$1.00-22.31%
2019-03-312019-05-10$3.03 million-$1.36-$1.20-13.1%
2018-12-312019-03-01$3.62 million-$1.28-$1.25-2.81%
2018-09-302018-11-09$4.49 million-$1.28-$1.24-2.89%
2018-06-302018-08-09$4.88 million-$1.23-$1.10-11.56%
2018-03-312018-05-09$1.42 million-$1.26-$0.91-38.97%
2017-12-312018-03-12$1.68 million-$1.10-$1.04-5.43%
2017-09-302017-11-09$1.32 million-$0.94-$0.984.08%
2017-06-302017-08-09$1.1 million-$0.92-$0.81-13.23%
2017-03-312017-05-10$383000-$0.89-$0.76-17.49%
2016-12-312017-03-16$676000-$0.81-$0.67-20.45%
2016-09-302016-11-09$392000-$0.75-$0.53-41.51%
2016-06-302016-08-15$417000-$0.51-$0.37-37.84%
2016-03-312016-05-16$N/A-$0.36-$0.396.9%
2015-12-312016-03-30$N/A-$0.47-$0.32-46.88%
2015-09-302015-11-11$26000-$0.54-$0.29-86.21%

Wave Life Sciences Ltd (WVE) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Wave Life Sciences Ltd (WVE) Chart:

Wave Life Sciences Ltd (WVE) News:

Below you will find a list of latest news for Wave Life Sciences Ltd (WVE) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Wave Life Sciences Ltd (WVE) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-04-1714.8CALL2 00TRUE4.80
2026-04-172.517.15CALL0 30TRUE00
2026-04-1741.56CALL16 5145.1TRUE1.560
2026-04-1751.29CALL746 10881.77TRUE1.290
2026-04-1760.7CALL4280 5298.66TRUE0.70
2026-04-177.50.2CALL2085 26797.5FALSE0.20
2026-04-1790.08CALL171 342110.67FALSE0.080
2026-04-17100.05CALL106 1910119.23FALSE-2.95-0.98
2026-04-17110.03CALL11 869158.55FALSE-2.47-0.99
2026-04-1712.50.05CALL1604 3032159.3FALSE-1.7-0.97
2026-04-17140.04CALL47 1520171.87FALSE-1.16-0.97
2026-04-17150.05CALL397 17541189.97FALSE-1-0.95
2026-04-17160.01CALL23 9945159.53FALSE-0.79-0.99
2026-04-1717.50.01CALL200 3303171.91FALSE-0.64-0.98
2026-04-17190.04CALL39 3580219.93FALSE-0.26-0.87
2026-04-17200.05CALL31 2064235.59FALSE-0.3-0.86
2026-04-17210.3CALL0 169243.04FALSE00
2026-04-17220.13CALL0 2602250.09FALSE00
2026-04-17230.03CALL3 2076238.63FALSE0.030
2026-04-17240.3CALL0 119263.1FALSE00
2026-04-17250.03CALL25 409250.47FALSE0.030
2026-04-17260.2CALL0 19274.89FALSE00
2026-04-17270.74CALL0 5280.39FALSE00
2026-04-17280.45CALL0 327285.65FALSE00
2026-04-17290.29CALL0 8290.7FALSE00
2026-04-17300.03CALL15 835275.81FALSE0.030
2026-04-17310.6CALL0 60300.23FALSE00
2026-04-17320CALL0 0400.27FALSE00
2026-04-17330.93CALL0 10309.06FALSE00
2026-04-17340CALL0 0410.03FALSE00
2026-04-17350.2CALL0 862317.3FALSE00
2026-04-1710PUT0 0449.5FALSE00
2026-04-172.50.05PUT15 34231.25FALSE0.050
2026-04-1740.09PUT281 277144.5FALSE0.090
2026-04-1750.14PUT1369 12099.87FALSE0.140
2026-04-1760.4PUT332 32683.71FALSE0.40
2026-04-177.51.55PUT115 3024110.18TRUE1.550
2026-04-1792.7PUT77 1218104.45TRUE2.244.87
2026-04-17103.75PUT309 2976125.69TRUE3.14.77
2026-04-17114.7PUT945 2656144.16TRUE3.52.92
2026-04-1712.56.85PUT294 4412168.09TRUE4.752.26
2026-04-17148.5PUT54 2736188.65TRUE8.50
2026-04-17159.45PUT127 1495200.92TRUE9.450
2026-04-17164.59PUT0 1692212.25TRUE00
2026-04-1717.511.31PUT10 1783193.89TRUE11.310
2026-04-17194.3PUT0 1830TRUE00
2026-04-172016.8PUT1 1430TRUE16.80
2026-04-17218.5PUT0 1220TRUE00
2026-04-17226.2PUT0 1010TRUE00
2026-04-17236.5PUT0 220TRUE00
2026-04-172410.9PUT0 270TRUE00
2026-04-17250PUT0 0485.39TRUE00
2026-04-172611.8PUT0 0451.93TRUE00
2026-04-17270PUT0 0436.43TRUE00
2026-04-17280PUT0 0454.71TRUE00
2026-04-17290PUT0 0472.36TRUE00
2026-04-17300PUT0 0467.42TRUE00
2026-04-173116PUT0 0526.29TRUE00
2026-04-17320PUT0 0532.2TRUE00
2026-04-173317PUT0 0537.89TRUE00
2026-04-17340PUT0 0543.38TRUE00
2026-04-17350PUT0 0538.61TRUE00
2026-05-1551.55CALL134 096.76TRUE1.550
2026-05-1560.95CALL1103 092.81TRUE0.950
2026-05-1570.55CALL1326 091.06FALSE0.550
2026-05-1580.35CALL818 095.79FALSE0.350
2026-05-1590.2CALL13 095.31FALSE0.20
2026-05-15100.15CALL4 0102.51FALSE0.150
2026-05-15110.1CALL3 3104.79FALSE0.10
2026-05-15120.05CALL5 5100.62FALSE-2-0.98
2026-05-15130.2CALL201 201148.24FALSE0.20
2026-05-15140.06CALL3 342122.03FALSE-1.44-0.96
2026-05-15150.1CALL251 16142.98FALSE-1.35-0.93
2026-05-15160CALL0 0202FALSE00
2026-05-15170.93CALL0 2209.9FALSE00
2026-05-15180CALL0 0217.22FALSE00
2026-05-15190CALL0 0224.02FALSE00
2026-05-15200.05CALL1 1155.97FALSE0.050
2026-05-15210CALL0 0236.36FALSE00
2026-05-1550.35PUT76 0100.42FALSE0.350
2026-05-1560PUT0 093.21FALSE00
2026-05-1570PUT0 089TRUE00
2026-05-1580PUT0 096.86TRUE00
2026-05-1590.95PUT0 15088.33TRUE00
2026-05-15104.15PUT27 0139.76TRUE4.150
2026-05-15115.74PUT25 0147.99TRUE5.740
2026-05-15120PUT0 0182.72TRUE00
2026-05-15130PUT0 0195.08TRUE00
2026-05-15140PUT0 0206.22TRUE00
2026-05-15150PUT0 0223.28TRUE00
2026-05-15160PUT0 0232.64TRUE00
2026-05-15170PUT0 0241.29TRUE00
2026-05-15180PUT0 0256.23TRUE00
2026-05-15190PUT0 0256.83TRUE00
2026-05-15200PUT0 0263.86TRUE00
2026-05-15210PUT0 0270.49TRUE00
2026-07-1710CALL0 00TRUE00
2026-07-1725.7CALL0 30111.58TRUE00
2026-07-1730CALL0 0103.9TRUE00
2026-07-1740CALL0 0104.54TRUE00
2026-07-1752.1CALL151 18114.04TRUE-5.7-0.73
2026-07-1761.65CALL224 20114.19TRUE1.650
2026-07-1771.05CALL130 096FALSE1.050
2026-07-1780.9CALL947 2104.94FALSE0.90
2026-07-1790.71CALL50 0106.2FALSE0.710
2026-07-17100.7CALL10 14118.02FALSE0.70
2026-07-17113CALL0 58116.48FALSE00
2026-07-17120.36CALL10 77108.25FALSE0.360
2026-07-17130.25CALL21 185104.12FALSE0.250
2026-07-17140.15CALL34 34197.48FALSE-1.85-0.93
2026-07-17150.25CALL5 700116.78FALSE-1.65-0.87
2026-07-17160.25CALL6 104122.3FALSE0.250
2026-07-17170.24CALL1 21126.1FALSE0.240
2026-07-17180.15CALL6 23117.66FALSE0.150
2026-07-17190.18CALL1 91126.63FALSE0.180
2026-07-17200.05CALL23 140103.31FALSE0.050
2026-07-17210.18CALL13 10134.33FALSE0.180
2026-07-17220CALL0 0166.04FALSE00
2026-07-17231.74CALL3 1279.24FALSE1.740
2026-07-17241.25CALL0 9173.02FALSE00
2026-07-17250.1CALL1 333132.03FALSE-0.3-0.75
2026-07-17262.52CALL3 235346.97FALSE2.520
2026-07-17270.45CALL0 1182.24FALSE00
2026-07-17280.85CALL0 17185.04FALSE00
2026-07-17290.8CALL0 2187.72FALSE00
2026-07-17300.4CALL0 13190.29FALSE00
2026-07-17310.25CALL0 11192.76FALSE00
2026-07-17320.26CALL0 191189.2FALSE00
2026-07-17330.25CALL0 9197.41FALSE00
2026-07-17340.55CALL0 1193.64FALSE00
2026-07-17350.35CALL0 127195.74FALSE00
2026-07-1710PUT0 0234.15FALSE00
2026-07-1720.05PUT10 0125.52FALSE0.050
2026-07-1730.21PUT4 0124.32FALSE0.210
2026-07-1740.46PUT30 0117.54FALSE0.460
2026-07-1750.7PUT200 0100.73FALSE0.70
2026-07-1760.4PUT0 2136.96FALSE00
2026-07-1770.65PUT0 38132.45TRUE00
2026-07-1781.1PUT0 25116.12TRUE00
2026-07-1791.15PUT0 2126.77TRUE00
2026-07-17104.43PUT14 96119.58TRUE2.982.06
2026-07-17111.7PUT0 138128.42TRUE00
2026-07-17121.65PUT0 141125.58TRUE00
2026-07-17133PUT0 51129.59TRUE00
2026-07-17143.1PUT0 40127.5TRUE00
2026-07-17159.55PUT1 197174.51TRUE5.651.45
2026-07-17164.5PUT0 3155.47TRUE00
2026-07-17170PUT0 0161.5TRUE00
2026-07-17180PUT0 0167.12TRUE00
2026-07-17190PUT0 0172.38TRUE00
2026-07-17207.03PUT0 2177.34TRUE00
2026-07-17210PUT0 0182.01TRUE00
2026-07-17220PUT0 0191.16TRUE00
2026-07-172310.88PUT0 42156.08TRUE00
2026-07-17240PUT0 0199.41TRUE00
2026-07-172511.9PUT0 4207.88TRUE00
2026-07-17260PUT0 0211.57TRUE00
2026-07-17270PUT0 0215.1TRUE00
2026-07-17280PUT0 0213.8TRUE00
2026-07-17290PUT0 0221.74TRUE00
2026-07-17300PUT0 0242.48TRUE00
2026-07-17310PUT0 0227.91TRUE00
2026-07-17320PUT0 0226.1TRUE00
2026-07-17330PUT0 0251.38TRUE00
2026-07-17340PUT0 0231.65TRUE00
2026-07-17350PUT0 0234.3TRUE00
2026-10-1633.6CALL44 0110.99TRUE3.60
2026-10-1650CALL0 096.9TRUE00
2026-10-1661.45CALL28 0101.4TRUE1.450
2026-10-1670CALL0 097.68FALSE00
2026-10-1680CALL0 094.71FALSE00
2026-10-1690CALL0 096.98FALSE00
2026-10-16101CALL5 20103.93FALSE10
2026-10-16110CALL0 097.96FALSE00
2026-10-16124.15CALL0 61102FALSE00
2026-10-16130.4CALL35 1388.55FALSE0.40
2026-10-16140.5CALL10 12100.83FALSE0.50
2026-10-16150.5CALL13 10105.67FALSE0.50
2026-10-16160CALL0 0102.84FALSE00
2026-10-16170.35CALL3 5102.89FALSE0.350
2026-10-16181.58CALL0 2110.52FALSE00
2026-10-16190CALL0 0109.91FALSE00
2026-10-16200.25CALL5 6104.05FALSE0.250
2026-10-16212CALL0 1113.89FALSE00
2026-10-16251.38CALL0 3142.14FALSE00
2026-10-1630PUT0 095.6FALSE00
2026-10-1651.2PUT2 0110.43FALSE1.20
2026-10-1660PUT0 0115.76FALSE00
2026-10-1670PUT0 0116.07TRUE00
2026-10-1680PUT0 0120.1TRUE00
2026-10-1690PUT0 0124.3TRUE00
2026-10-16104.55PUT10 099.03TRUE4.550
2026-10-16110PUT0 0121.89TRUE00
2026-10-16123.02PUT0 10118.5TRUE00
2026-10-16132.95PUT0 12119.59TRUE00
2026-10-16140PUT0 0122.85TRUE00
2026-10-16150PUT0 092.6TRUE00
2026-10-16160PUT0 0136.85TRUE00
2026-10-16170PUT0 0144.75TRUE00
2026-10-16180PUT0 0130.16TRUE00
2026-10-16190PUT0 0137.75TRUE00
2026-10-16200PUT0 0138.28TRUE00
2026-10-16210PUT0 0142.02TRUE00
2026-10-16250PUT0 0147.81TRUE00
2026-12-1838.91CALL0 2795.51TRUE00
2026-12-1852.5CALL191 295.85TRUE2.50
2026-12-1860CALL0 089.18TRUE00
2026-12-1871.7CALL16 3092.04FALSE1.70
2026-12-1881.3CALL2 085.74FALSE1.30
2026-12-1890CALL0 085.42FALSE00
2026-12-18101CALL147 57990.33FALSE-3.9-0.8
2026-12-18114.1CALL0 291.43FALSE00
2026-12-18123.7CALL0 17391.31FALSE00
2026-12-18130CALL0 096.75FALSE00
2026-12-18140CALL0 093.48FALSE00
2026-12-18150.7CALL144 420103.36FALSE0.70
2026-12-18160CALL0 095.85FALSE00
2026-12-18172.57CALL0 8593.01FALSE00
2026-12-18183.2CALL0 54189.12FALSE00
2026-12-18200.4CALL20 195102.05FALSE0.40
2026-12-18220.32CALL9 61101.25FALSE0.320
2026-12-18250.3CALL10 126106.17FALSE-0.9-0.75
2026-12-18274CALL0 2127.92FALSE00
2026-12-18300.5CALL2 95130.03FALSE-0.25-0.33
2026-12-18321.3CALL0 2136.56FALSE00
2026-12-18350.19CALL21 217111.71FALSE-0.33-0.63
2026-12-1830PUT0 093.16FALSE00
2026-12-1851.05PUT66 088.39FALSE1.050
2026-12-1860PUT0 086.41FALSE00
2026-12-1872.55PUT1 92102.69TRUE2.550
2026-12-1880PUT0 0103.98TRUE00
2026-12-1890PUT0 0103.09TRUE00
2026-12-18101.97PUT0 61107.64TRUE00
2026-12-18110PUT0 0108.47TRUE00
2026-12-18124.42PUT0 15105.66TRUE00
2026-12-18137.3PUT2 296.17TRUE7.30
2026-12-18140PUT0 079.09TRUE00
2026-12-18159.58PUT79 110121.78TRUE4.580.92
2026-12-18160PUT0 0127.6TRUE00
2026-12-181711.78PUT5 5141.1TRUE11.780
2026-12-18186.9PUT0 3119.82TRUE00
2026-12-18209.58PUT0 10124.28TRUE00
2026-12-18229.51PUT0 2130.88TRUE00
2026-12-182511.2PUT0 21139.67TRUE00
2026-12-182713.9PUT0 96118.21TRUE00
2026-12-18300PUT0 0155.2TRUE00
2026-12-18320PUT0 0159.64TRUE00
2026-12-18350PUT0 0165.82TRUE00
2027-01-1533.9CALL85 0120.73TRUE3.90
2027-01-1552.5CALL306 090.82TRUE2.50
2027-01-1580CALL0 091.49FALSE00
2027-01-15101.02CALL10 086.64FALSE1.020
2027-01-15120CALL0 099.77FALSE00
2027-01-15150CALL0 085.89FALSE00
2027-01-15170.3CALL3 081.58FALSE0.30
2027-01-15200.34CALL17 092.85FALSE0.340
2027-01-15220CALL0 0106.65FALSE00
2027-01-1530PUT0 0109.59FALSE00
2027-01-1551.5PUT4 0110.52FALSE1.50
2027-01-1583.01PUT54 086.28TRUE3.010
2027-01-15100PUT0 094TRUE00
2027-01-15120PUT0 091.7TRUE00
2027-01-15150PUT0 0112.96TRUE00
2027-01-15170PUT0 0121.76TRUE00
2027-01-15200PUT0 0132.97TRUE00
2027-01-15220PUT0 0125.98TRUE00
2027-06-1730CALL0 083.52TRUE00
2027-06-1752.52CALL136 072.96TRUE2.520
2027-06-1782.1CALL81 094.72FALSE2.10
2027-06-17100CALL0 091.49FALSE00
2027-06-17120CALL0 098.51FALSE00
2027-06-17151.1CALL9 094.67FALSE1.10
2027-06-17170CALL0 094.05FALSE00
2027-06-17200CALL0 0100.59FALSE00
2027-06-17220CALL0 0102.79FALSE00
2027-06-1730PUT0 0102.18FALSE00
2027-06-1751.7PUT1 0101.29FALSE1.70
2027-06-1780PUT0 098.51TRUE00
2027-06-17100PUT0 097.9TRUE00
2027-06-17120PUT0 0101.03TRUE00
2027-06-17150PUT0 096.08TRUE00
2027-06-17170PUT0 0105.78TRUE00
2027-06-17200PUT0 0113.52TRUE00
2027-06-17220PUT0 0119.19TRUE00
2028-01-2134.2CALL36 096.15TRUE4.20
2028-01-2150CALL0 097.23TRUE00
2028-01-2182.5CALL4 089.33FALSE2.50
2028-01-21102.32CALL21 095.21FALSE2.320
2028-01-21120CALL0 082.74FALSE00
2028-01-21150CALL0 093.36FALSE00
2028-01-21170CALL0 088.74FALSE00
2028-01-21201.25CALL4 092.8FALSE1.250
2028-01-21220CALL0 090.07FALSE00
2028-01-2130.63PUT8 084.13FALSE0.630
2028-01-2151.87PUT38 092.39FALSE1.870
2028-01-2183.6PUT2 080.55TRUE3.60
2028-01-21100PUT0 096.24TRUE00
2028-01-21120PUT0 089.92TRUE00
2028-01-211510.05PUT50 0100.97TRUE10.050
2028-01-21170PUT0 098.46TRUE00
2028-01-21200PUT0 098.9TRUE00
2028-01-21220PUT0 0103.97TRUE00

Latest WVE Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST17$1.995
Jun 13, 2022 7:59 PM EST100$2
Jun 13, 2022 7:59 PM EST17$1.995
Jun 13, 2022 7:59 PM EST17$1.995
Jun 13, 2022 7:59 PM EST100$1.995

Wave Life Sciences Ltd (WVE) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2019-08-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1631574/000000000019012261/0000000000-19-012261-index.htm
2019-11-27UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1631574/000000000019015921/0000000000-19-015921-index.htm
2019-12-06UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1631574/000000000019016177/0000000000-19-016177-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000008025519002715/0000080255-19-002715-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000008025520001311/0000080255-20-001311-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000021545719006909/0000215457-19-006909-index.htm
2019-03-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000021545719007594/0000215457-19-007594-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000083423720008192/0000834237-20-008192-index.htm
2020-08-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000089542120000470/0000895421-20-000470-index.htm
2018-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318022514/0000899243-18-022514-index.htm
2018-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318022515/0000899243-18-022515-index.htm
2018-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318025318/0000899243-18-025318-index.htm
2018-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318025320/0000899243-18-025320-index.htm
2018-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2018-11-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924318029157/0000899243-18-029157-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004460/0000899243-19-004460-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004462/0000899243-19-004462-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004464/0000899243-19-004464-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004466/0000899243-19-004466-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319004467/0000899243-19-004467-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007106/0000899243-19-007106-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007110/0000899243-19-007110-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007112/0000899243-19-007112-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007113/0000899243-19-007113-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319007114/0000899243-19-007114-index.htm
2019-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-07-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319019395/0000899243-19-019395-index.htm
2019-08-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021292/0000899243-19-021292-index.htm
2019-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021293/0000899243-19-021293-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021959/0000899243-19-021959-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021962/0000899243-19-021962-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021963/0000899243-19-021963-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021965/0000899243-19-021965-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021966/0000899243-19-021966-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319021967/0000899243-19-021967-index.htm
2019-09-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023028/0000899243-19-023028-index.htm
2019-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023032/0000899243-19-023032-index.htm
2019-09-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023033/0000899243-19-023033-index.htm
2019-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023034/0000899243-19-023034-index.htm
2019-09-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023035/0000899243-19-023035-index.htm
2019-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319023038/0000899243-19-023038-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319027985/0000899243-19-027985-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924319028606/0000899243-19-028606-index.htm
2020-01-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320001393/0000899243-20-001393-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320003379/0000899243-20-003379-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320005342/0000899243-20-005342-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320005346/0000899243-20-005346-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320005349/0000899243-20-005349-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320005351/0000899243-20-005351-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007277/0000899243-20-007277-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007281/0000899243-20-007281-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007282/0000899243-20-007282-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007284/0000899243-20-007284-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320007285/0000899243-20-007285-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023078/0000899243-20-023078-index.htm
2020-08-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023079/0000899243-20-023079-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023080/0000899243-20-023080-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023085/0000899243-20-023085-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023086/0000899243-20-023086-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023087/0000899243-20-023087-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023088/0000899243-20-023088-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023089/0000899243-20-023089-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023092/0000899243-20-023092-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023093/0000899243-20-023093-index.htm
2020-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320023540/0000899243-20-023540-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000089924320025614/0000899243-20-025614-index.htm
2020-01-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000090221920000204/0000902219-20-000204-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000110465920021834/0001104659-20-021834-index.htm
2019-01-28SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1631574/000114420419003157/0001144204-19-003157-index.htm
2019-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1631574/000114420419003160/0001144204-19-003160-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000114420419008078/0001144204-19-008078-index.htm
2018-09-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518270464/0001193125-18-270464-index.htm
2018-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518290300/0001193125-18-290300-index.htm
2018-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518291962/0001193125-18-291962-index.htm
2018-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518295345/0001193125-18-295345-index.htm
2018-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518323137/0001193125-18-323137-index.htm
2018-11-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312518323760/0001193125-18-323760-index.htm
2018-12-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312518342992/0001193125-18-342992-index.htm
2019-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519001144/0001193125-19-001144-index.htm
2019-01-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1631574/000119312519014851/0001193125-19-014851-index.htm
2019-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519014884/0001193125-19-014884-index.htm
2019-01-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1631574/000119312519015961/0001193125-19-015961-index.htm
2019-01-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519015976/0001193125-19-015976-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519040844/0001193125-19-040844-index.htm
2019-02-20SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1631574/000119312519045277/0001193125-19-045277-index.htm
2019-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519059251/0001193125-19-059251-index.htm
2019-03-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1631574/000119312519074933/0001193125-19-074933-index.htm
2019-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519107259/0001193125-19-107259-index.htm
2019-04-2910-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1631574/000119312519125660/0001193125-19-125660-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519143674/0001193125-19-143674-index.htm
2019-05-10S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1631574/000119312519144278/0001193125-19-144278-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519165571/0001193125-19-165571-index.htm
2019-06-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519182697/0001193125-19-182697-index.htm
2019-07-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519205421/0001193125-19-205421-index.htm
2019-08-06S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1631574/000119312519214152/0001193125-19-214152-index.htm
2019-08-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519214169/0001193125-19-214169-index.htm
2019-08-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1631574/000119312519218981/0001193125-19-218981-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519221246/0001193125-19-221246-index.htm
2019-08-168-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519223468/0001193125-19-223468-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519238229/0001193125-19-238229-index.htm
2019-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519263797/0001193125-19-263797-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519284729/0001193125-19-284729-index.htm
2019-11-05S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519284817/0001193125-19-284817-index.htm
2019-12-03CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1631574/000119312519304738/0001193125-19-304738-index.htm
2019-12-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519314469/0001193125-19-314469-index.htm
2019-12-23SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000119312519322733/0001193125-19-322733-index.htm
2019-12-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312519325442/0001193125-19-325442-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520005483/0001193125-20-005483-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520005882/0001193125-20-005882-index.htm
2020-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520026760/0001193125-20-026760-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520037841/0001193125-20-037841-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520038291/0001193125-20-038291-index.htm
2020-03-02POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/1631574/000119312520057766/0001193125-20-057766-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520057791/0001193125-20-057791-index.htm
2020-03-02POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1631574/000119312520057905/0001193125-20-057905-index.htm
2020-04-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520107212/0001193125-20-107212-index.htm
2020-04-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520117339/0001193125-20-117339-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520138276/0001193125-20-138276-index.htm
2020-06-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520181069/0001193125-20-181069-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520214106/0001193125-20-214106-index.htm
2020-08-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520214144/0001193125-20-214144-index.htm
2020-08-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1631574/000119312520214223/0001193125-20-214223-index.htm
2020-08-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520223731/0001193125-20-223731-index.htm
2020-08-198-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520224764/0001193125-20-224764-index.htm
2020-08-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520229903/0001193125-20-229903-index.htm
2020-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520241608/0001193125-20-241608-index.htm
2020-09-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1631574/000119312520251261/0001193125-20-251261-index.htm
2020-09-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520251297/0001193125-20-251297-index.htm
2020-09-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1631574/000119312520252307/0001193125-20-252307-index.htm
2020-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520252347/0001193125-20-252347-index.htm
2020-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520254552/0001193125-20-254552-index.htm
2020-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1631574/000119312520260543/0001193125-20-260543-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000127417319000113/0001274173-19-000113-index.htm
2019-08-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000127417319000120/0001274173-19-000120-index.htm
2020-01-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000127417320000004/0001274173-20-000004-index.htm
2020-01-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1631574/000149315220000835/0001493152-20-000835-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459018028757/0001564590-18-028757-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1631574/000156459019005671/0001564590-19-005671-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459019018521/0001564590-19-018521-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459019029396/0001564590-19-029396-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459019040431/0001564590-19-040431-index.htm
2020-03-0210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1631574/000156459020007972/0001564590-20-007972-index.htm
2020-04-2910-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1631574/000156459020019772/0001564590-20-019772-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459020023860/0001564590-20-023860-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1631574/000156459020038620/0001564590-20-038620-index.htm
2019-08-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1631574/999999999519001883/9999999995-19-001883-index.htm
2020-05-01EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1631574/999999999520000974/9999999995-20-000974-index.htm
2018-09-17CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1631574/999999999718007937/9999999997-18-007937-index.htm

Wave Life Sciences Ltd (WVE) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Wave Life Sciences Ltd (WVE). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1297%
Institutional Ownership: 7671%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-02-19Keith RegnanteChief Financial OfficerSell1,298.0036.8447,817.8015,686.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004467/0000899243-19-004467-index.htm
2018-09-24Keith RegnanteChief Financial OfficerSell29,500.0055.001,622,500.0016,984.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025320/0000899243-18-025320-index.htm
2019-02-19Chris FrancisOfficerSell1,709.0036.8462,959.0520,368.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004460/0000899243-19-004460-index.htm
2018-09-24Chris FrancisOfficerSell1,032.0056.0057,792.0022,077.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2018-09-25Chris FrancisOfficerSell10,543.0056.00590,408.0022,077.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2018-09-24Chris FrancisOfficerBuy1,032.002.482,559.3623,109.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2019-02-19Chandra VargeeseSenior VP, Drug DiscoverySell2,055.0036.8475,706.2025,245.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004462/0000899243-19-004462-index.htm
2019-02-19PAUL BOLNOPresident and CEOSell119.0037.474,458.45271,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004464/0000899243-19-004464-index.htm
2019-02-19PAUL BOLNOPresident and CEOSell7,614.0036.38276,997.32271,328.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004464/0000899243-19-004464-index.htm
2020-07-02PAUL BOLNOPresident and CEOSell43,068.0010.26441,877.68272,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-07-02PAUL BOLNOPresident and CEOSell95,921.0010.27985,108.67272,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-08-25PAUL BOLNOPresident and CEOSell25,000.0012.00300,000.00272,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320023540/0000899243-20-023540-index.htm
2020-09-15PAUL BOLNOPresident and CEOSell100,000.0015.001,500,000.00272,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320025614/0000899243-20-025614-index.htm
2018-09-24Chandra VargeeseSenior VP, Drug DiscoverySell3,000.0055.00165,000.0027,300.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025318/0000899243-18-025318-index.htm
2019-03-07Keith RegnanteChief Financial OfficerBuy13,500.0029,186.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007114/0000899243-19-007114-index.htm
2020-08-25PAUL BOLNOPresident and CEOBuy25,000.002.4862,000.00297,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320023540/0000899243-20-023540-index.htm
2019-11-20Gregory L. VerdineDirectorSell2,609.0032.7485,418.6630,000.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319027985/0000899243-19-027985-index.htm
2018-09-24Chandra VargeeseSenior VP, Drug DiscoveryBuy3,000.002.487,440.0030,300.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025318/0000899243-18-025318-index.htm
2020-02-18Chris FrancisOfficerSell2,708.007.8521,257.8031,160.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320005346/0000899243-20-005346-index.htm
2020-07-02PAUL BOLNOPresident and CEOSell4,509.0010.8248,787.38315,249.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-02-18PAUL BOLNOPresident and CEOSell11,451.007.8589,890.35319,758.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320005349/0000899243-20-005349-index.htm
2019-11-20Gregory L. VerdineDirectorSell3,400.0031.59107,406.0032,609.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319027985/0000899243-19-027985-index.htm
2018-09-25Chris FrancisOfficerBuy10,543.002.4826,146.6432,620.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025322/0000899243-18-025322-index.htm
2019-03-07PAUL BOLNOPresident and CEOBuy60,000.00331,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007112/0000899243-19-007112-index.htm
2019-03-15PAUL BOLNOPresident and CEOSell1,763.0046.0081,098.00331,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-03-15PAUL BOLNOPresident and CEOSell8,237.0045.22372,477.14332,972.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-03-07Chris FrancisOfficerBuy13,500.0033,868.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007110/0000899243-19-007110-index.htm
2019-03-15PAUL BOLNOPresident and CEOSell5,065.0045.89232,432.85341,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-03-15PAUL BOLNOPresident and CEOSell34,935.0045.451,587,795.75346,274.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-08-05Mark BaldryChief Commerical OfficerBuy35,000.0035,000.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319021293/0000899243-19-021293-index.htm
2019-11-20Gregory L. VerdineDirectorSell24,030.0030.27727,388.1036,009.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319027985/0000899243-19-027985-index.htm
2020-07-02PAUL BOLNOPresident and CEOSell4,079.0010.9144,501.89368,102.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-02-18Chandra VargeeseSenior VP, Drug DiscoverySell3,188.007.8525,025.8037,057.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320005342/0000899243-20-005342-index.htm
2020-07-02PAUL BOLNOPresident and CEOBuy100,000.002.48248,000.00372,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320018398/0000899243-20-018398-index.htm
2020-09-15PAUL BOLNOPresident and CEOBuy100,000.002.48248,000.00372,181.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320025614/0000899243-20-025614-index.htm
2019-02-19Michael A. PanzaraFranchise Lead, NeurologySell1,837.0036.8467,673.9837,388.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319004466/0000899243-19-004466-index.htm
2019-03-15PAUL BOLNOPresident and CEOBuy50,000.002.48124,000.00381,209.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319008404/0000899243-19-008404-index.htm
2019-08-05Mark BaldryChief Commerical OfficerBuy4,000.0039,000.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319021293/0000899243-19-021293-index.htm
2020-02-18Michael A. PanzaraChief Medical OfficerSell2,981.007.8523,400.8539,349.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320005351/0000899243-20-005351-index.htm
2019-03-07Chandra VargeeseSenior VP, Drug DiscoveryBuy15,000.0040,245.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007106/0000899243-19-007106-index.htm
2019-12-03Chandra VargeeseSenior VP, Drug DiscoverySell6,000.0035.00210,000.0040,245.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319028606/0000899243-19-028606-index.htm
2019-07-05Michael A. PanzaraChief Medical OfficerSell445.0027.2612,130.7042,330.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319019395/0000899243-19-019395-index.htm
2019-07-05Michael A. PanzaraChief Medical OfficerSell2,613.0026.8870,237.4442,775.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319019395/0000899243-19-019395-index.htm
2019-03-11Michael A. PanzaraFranchise Lead, NeurologySell7,000.0048.00336,000.0045,388.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007113/0000899243-19-007113-index.htm
2019-12-03Chandra VargeeseSenior VP, Drug DiscoveryBuy6,000.002.4814,880.0046,245.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319028606/0000899243-19-028606-index.htm
2018-09-24Keith RegnanteChief Financial OfficerBuy29,500.0020.89616,255.0046,484.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318025320/0000899243-18-025320-index.htm
2019-03-07Michael A. PanzaraFranchise Lead, NeurologyBuy15,000.0052,388.00https://www.sec.gov/Archives/edgar/data/1631574/000089924319007113/0000899243-19-007113-index.htm
2018-11-14Gregory L. VerdineDirectorSell4,300.0039.52169,936.0060,039.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318029157/0000899243-18-029157-index.htm
2020-02-03David G GaieroInterim CFOSell651.007.004,557.006,392.00https://www.sec.gov/Archives/edgar/data/1631574/000089924320003379/0000899243-20-003379-index.htm
2018-11-14Gregory L. VerdineDirectorSell10,700.0038.59412,913.0064,339.00https://www.sec.gov/Archives/edgar/data/1631574/000089924318029157/0000899243-18-029157-index.htm
2019-01-24RA CAPITAL MANAGEMENT, LLCDirectorBuy263,158.0038.0010,000,004.007,775,207.00https://www.sec.gov/Archives/edgar/data/1631574/000114420419003160/0001144204-19-003160-index.htm